Cura Sen Therapeutics, Inc announced it raised $15 Million in an initial filing from an offering of $15 Million

Company

Location

About

CuraSen Therapeutics, Inc. is a privately funded biopharmaceutical company pursuing development of novel treatments for neurodegenerative diseases, including Parkinson’s disease and Alzheimer’s disease, as well as several orphan indications. Millions of patients and their families are burdened by these diseases, and the numbers continue to grow annually with the aging population.